Same (S-Adenosyl Methionine) for Fibromyalgia

Research suggests that SAMe may offer some benefit for fibromyalgia, though the evidence base remains limited and preliminary. The available literature, synthesized in a 2017 systematic review of 132 studies spanning multiple neuropsychiatric and related medical conditions, found encouraging but inconclusive signals for SAMe across a broad range of conditions including fibromyalgia. The review noted that while findings are promising, the existing body of research carries meaningful methodological limitations, and the authors stopped short of drawing firm conclusions for any of the conditions examined. Overall, the research is suggestive rather than definitive, and further well-designed clinical trials focused specifically on fibromyalgia would be needed to clarify SAMe's role in managing this condition.